Skip to main content

How open-source drug discovery could help us in the next pandemic


The Download

Your daily dose of what's up in emerging technology

By Rhiannon Williams • 11.10.23

Hello, and happy Friday! Today: how collaborative drug discovery projects could help develop the antivirals we need to combat future pandemics. Plus: how one man has helped to shape the academic careers of some of computer science's brightest minds. Psst: it's not too late to register for our flagship event EmTech MIT 2023 next week—and readers of The Download get a special 30% discount.

How open-source drug discovery could help us in the next pandemic

When the covid pandemic hit, our antiviral coffers were bare. After all, developing drugs for diseases that don't pose an immediate threat isn't exactly lucrative. But what would happen if we took profit out of the equation and made drug discovery a collaborative process rather than a competitive one? 

The researchers behind the Covid Moonshot, an open-science initiative to develop antivirals that began back in March 2020, published their results this week. The effort produced 18,000 compound designs that led to the synthesis of 2,400 compounds. One of those became the basis for what is now the project's lead candidate: a compound that targets the coronavirus's main viral enzyme.

Maybe that doesn't feel like a huge win. Even if the compound works, it will likely take many more years to develop it into a drug. But the need for another antiviral that's ready for the next pandemic or next outbreak or the next variant is still very relevant. Read the full story.

—Cassandra Willyard
 

This story is from The Checkup, MIT Technology Review's weekly biotech newsletter. Sign up to receive it in your inbox every Thursday.

How this Turing Award–winning researcher became a legendary academic advisor

Every academic field has its superstars. But a rare few achieve superstardom not just by demonstrating individual excellence but also by consistently producing future superstars.

Computer science has its own such figure: Manuel Blum, who won the 1995 Turing Award—the Nobel Prize of computer science. He is the inventor of the captcha—a test designed to distinguish humans from bots online.

Three of Blum's students have also won Turing Awards, and many have received other high honors in theoretical computer science, such as the Gödel Prize and the Knuth Prize. More than 20 hold professorships at top computer science departments. But is there some formula to his success? Read the full story.

—Sheon Han


This story is from our most recent print issue of MIT Technology Review, which is all about society's hardest problems, and how we should tackle them. If you don't already, subscribe now to get future issues when they land.

The must-reads

I've combed the internet to find you today's most fun/important/scary/fascinating stories about technology.

1 Humane wants to sell us a future of 'ambient computing' 
The company wants to liberate us from smartphones—via even more technology. (NYT $)
+ The voice and touch-only interface sounds pretty fiddly. (TechCrunch)
+ What are we supposed to use it for, exactly? (The Verge)

2 Google has launched a new anti-terrorism content tool
Altitude gives smaller platforms the ability to track, detect and remove terror content. (Wired $)
+ Google has a new tool to outsmart authoritarian internet censorship. (MIT Technology Review)
 
3 Apple's €14.3 billion tax dispute is back on the agenda  
An EU court decision from 2020 has been called into question, and a new assessment could be on the horizon. (FT $)
+ It's been ordered to pay $25 million in a hiring discrimination case, too. (The Verge)

4 Video chat site Omegle is no more
A recent lawsuit found it gave sexual predators free rein. (Fast Company $)
+ The site had a long, problematic history of sexual abuse issues. (Wired $)

5 Meta is staging a bold return to China
Over a decade after Facebook was blocked from operating there. (WSJ $)
+ The company needs China more than it's willing to admit. (Rest of World)

6 Labcorp's workers say they're burnt out
Its rigid productivity targets are pushing them to the brink. (404 Media)
 
7 Amazon is officially a fashion flop 🛍️
Its hopes of becoming a bricks and mortar clothing giant have been dashed. (The Information $)
+ The war over fast fashion is heating up. (MIT Technology Review)
 
8 OnlyFans is the pathway to succeed as an adult performer
The platform dominates the industry, but its stars don't care. (WP $)
+ Fame in the age of AI looks a little different these days. (Economist $)
 
9 Meet the disaster microbiologists
Catastrophes can alter the environment, and microbes that affect our health, forever. (Proto.Life)
+ Your microbiome ages as you do—and that's a problem. (MIT Technology Review)

10 Hollywood's old guard are unlikely TikTok sensations
Iconic directors are staring down entirely different lenses—and they like what they see. (The Guardian)

Quote of the day


"It was just freaking out. Broken needles. Chaos."

—Amardeep Singh, a UX designer, describes the carnage caused when he tried to feed an old-school sewing machine a modern fabric to the Wall Street Journal.

The big story

How scientists want to make you young again

October 2022

A little over 15 years ago, scientists at Kyoto University in Japan made a remarkable discovery.

When they added just four proteins to a skin cell and waited about two weeks, some of the cells underwent an unexpected and astounding transformation: they became young again. They turned into stem cells almost identical to the kind found in a days-old embryo, just beginning life's journey.

Now, after more than a decade of studying and tweaking so-called cellular reprogramming, a number of biotech companies and research labs say they have tantalizing hints that the process could be the gateway to an unprecedented new technology for age reversal. Read the full story 
 

—Antonio Regalado

We can still have nice things

A place for comfort, fun and distraction to brighten up your day. (Got any ideas? Drop me a line or tweet 'em at me.)

+ Say hello to the Kenyan volcano toad: a newly-discovered amphibian with a penchant for chilling in high-risk locations.
+ Talking of volcanoes, scientist Jackie Caplan-Auerbach knows how to tune into their songs (yes really!)
+ David Lynch, Toto, and Dune: what a combo.
+ Kick back and relax with this list of the greatest debut albums—there's some real bangers in there.
+ I'll have my pizza with a side order of Pearl Jam, please.

Subscribe for $8/month

For a limited time, save 25% on an annual subscription to MIT Technology Review and gain access to our Hard Problems edition, which explores technology's role in solving the world's most pressing issues.

SUBSCRIBE FOR $8/MONTH
EmTech MIT

Register now. Two days of innovation and inspiration on the MIT campus. November 14-15, 2023.

Top image credit: STEPHANIE ARNETT/MITTR | GETTY, NASA

Please send even dough to hi@technologyreview.com.

Follow me on Twitter at @yannon_. Thanks for reading!

—Rhiannon


Was this newsletter forwarded to you, and you'd like to see more?

Sign up today →
LinkedIn
Twitter
Facebook
View in browser | This email was sent to manojdole1.InformationTech@blogger.com.

Manage your preferences | Unsubscribe | Terms of Service | Privacy Policy

MIT Technology Review · 196 Broadway, 3rd fl, · Cambridge, MA 02139 · USA

Copyright © 2023 MIT Technology Review, All rights reserved.

Opt out of all promotional emails and newsletters from MIT Technology Review

Comments

Popular posts from this blog

Startups Weekly: Trouble in EV land and Peloton is circling the drain

Plus: The quirky rabbit R1 and Tesla's relationship with lidar View this email online in your browser ...

US investigates Fisker Ocean again, this time for braking randomly

U.S. regulators have opened their FOURTH probe of Fisker's Ocean SUV View this email online in your browser ...

How three filmmakers created Sora’s latest stunning videos

What's next for generative video ...